Cardiac surgery without transfusion in 2005;Chirurgie cardiaque sans transfusion en 2005

Archives des Maladies du Coeur et des Vaisseaux

Volumn 98, Issue 1, 2005, Pages 7-12

  Vaislic, C ^a,b   Bical, O ^a,b   Deleuze, P ^a,b   Khoury, W ^a,b   Gaillard, D ^a,b   Ponzio, O ^a,b   Ollivier, Y ^a   Robine, B ^a   Dupuys, C ^a   Sportiche, M ^a  

^a CMC Parly 2   (France)

^b SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; AGED; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CORONARY ARTERY SURGERY; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEART VALVE REPLACEMENT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; JEHOVAH'S WITNESS; MAJOR CLINICAL STUDY; MORTALITY; PREOPERATIVE TREATMENT; RELIGIOUS GROUP; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; BLOOD TRANSFUSION; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 19944432636     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Vuylsteke A, Gerrard G, Cross M. Reducing blood transfusion. BMJ 2002; 325: 655.
2. DeBois WJ, Sukhram Y, McVey J et al. Reduction in homologous blood transfusions using a low prime circuit. J Extracorpor Technol 1990; 28: 239-43.
3. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-6.
4. Speiss B. Transfusion and outcome in heart surgery. Ann Thorac Surg 2002; 74: 980-7.
5. Helm RE, Rosengart TK, Gomez M et al. Comprehensive Multi-modality Blood Conservation: 100 Consecutive CABG Operations without transfusion. Ann Thorac Surg 1998; 65: 125-36.
6. Rosengart TK, Helm B, Velasco F et al. Open heart surgery without transfusion: a multimodality strategy in over forty consecutive Jehovah's Witness patients. J Am Coll Cardiol 1996; 27 (Suppl. A): 231 A.
7. Rosengart TK, Helm RE, DeBois WJ et al. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients. J Am Coll Surg 1997; 184: 618-29.
8. Dor V, Memet B, Kreitmann P et al. Chirurgie cardiaque chez les témoins de Jéhovah. Arch Mal Cœur 1977; 5: 549-54.
9. Lewis CT, Murphy MC, Cooley DA. Risk factors for cardiac operations in adult Jehovah's Witnesses. Ann Thorac Surg 1991; 51: 448-50.
10. Ott DA, Cooley DA. Cardiovascular surgery in Jehovah's Witnesses. JAMA 1977; 238: 1256-8.
11. Larrazet F, Philippe F, Folliguet T et al. Comparaison de la voie radiale et de la voie fémorale dans l'angioplastie coronaire ad hoc. Arch Mal Cœur 2003; 96: 175-80.
12. Vaislic C, Bical O, Farge C et al. Totally Minimised Extracorporeal Circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses. Heart Surg Forum 2003; 6: 307-10.
13. Rosengart TK, DeBois WJ, Helm RE et al. Retrograde autologous priming (RAP) for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirement. Circulation 1995; 92 (Suppl. 1): 763.
14. Balachandran S, Cross MH, Karthikeyan S et al. Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery. Ann Thorac Surg 2002; 73: 1912-8.
15. Habib RH, Zacharias A, Schwann TA et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg 2003; 125: 1438-50.
16. Spence RK, Alexander JB, DelRossi AJ et al. T ansfusion guidelines for cardiovascular surgery. J Vasc Surg 1992; 16: 825-31.
17. Van der Linden P, De Hert S, Daper A et al. A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery. Can J Anesth 2001; 48: 894-901.
18. Magovern JA, Sakert T, Benckart DH et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 27-32. Ann Thorac Surg 1991; 51: 448-50.
19. Magovern JA, Sakert T, Benckart DH et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 27-32. Ann Thorac Surg 1991; 51: 448-50.
20. Levy JH, Pifarre R, Schaff HV et al. A multicenter double blind placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass qrafting. Circulation 1995; 92: 2230-44.
21. Bertrand P, Mazzucotelli JP, Loisance D et al. Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment. Arch Mal Cœur 1993; 86: 1471-4.
22. O'Brien MF. Harrocks S, Clarke A et al. How to do safe sternal reentry and the risk factors of redo cardiac surgery: a 21-year review with zero major cardiac injury. J Card Surg 2002; 17: 4-13.